Date Filed | Type | Description |
12/28/2017 |
GN
| Market Trends Toward New Normal in Veeco Instruments, Potlatch, Black Hills, Exactech, Insteel Industries, and First Cash — Emerging Consolidated Expectations, Analyst Ratings |
12/27/2017 |
GN
| LAWSUIT ALERT – Andrews & Springer LLC Announces That A Securities Class Action Has Been Filed Against Exactech, Inc. - EXAC |
10/25/2017 |
BW
| Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017 |
10/12/2017 |
BW
| Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call |
07/27/2017 |
BW
| Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue |
07/13/2017 |
BW
| Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call |
04/25/2017 |
BW
| Exactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth |
04/12/2017 |
BW
| Exactech Schedules First Quarter 2017 Earnings Release and Conference Call |
02/21/2017 |
BW
| Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million |
02/13/2017 |
BW
| Exactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call |
07/20/2011 |
BW
| Exactech Schedules Second Quarter 2011 Earnings Release and Conference Call |
05/12/2011 |
BW
| Exactech to Present at the 2011 Noble Financial Equity Conference on May 16 |
04/28/2011 |
BW
| Exactech Announces Full Market Release of the Equinoxe® Shoulder Fracture Plate |
04/20/2011 |
BW
| Exactech Schedules First Quarter 2011 Earnings Release and Conference Call |
02/28/2011 |
BW
| Exactech 2010 Revenue Up 7% to $190.5 Million |
02/14/2011 |
BW
| Exactech Announces Product Lineup for Exhibit at American Academy of Orthopaedic Surgeons Meeting Management to Present at Investor Conference |
02/10/2011 |
BW
| Exactech Announces 2010 Sales of $190.5 Million and 4th Quarter 2010 Sales of $51.8 Million |
12/07/2010 |
BW
| Exactech Announces Resolution of Government Investigation |
11/02/2010 |
BW
| Exactech Q3 Revenue $42.0M; EPS $0.11 Market Leading Extremity Growth at 33% |
10/18/2010 |
BW
| Exactech Says Q3 Financial Results Below Expectations |
08/27/2010 |
BW
| Exactech Acquires Minimally Invasive Spine Reconstruction Portfolio |
08/09/2010 |
BW
| Exactech To Present at Upcoming Investor Conferences |
07/16/2010 |
BW
| Exactech Schedules Second Quarter 2010 Earnings Release and Conference Call |
04/27/2010 |
BW
| Exactech Q1 Revenue Up 13%, Net Income Up 33% Reflecting Strong Surge in International Orthopaedic Sales and Decreased Legal Costs |
04/15/2010 |
BW
| Exactech Approved to Begin Marketing Novation® Hip System in High Demand Asian Market |
04/13/2010 |
BW
| Exactech Schedules First Quarter 2010 Earnings Release and Conference Call |
03/02/2010 |
BW
| Exactech Platform Fracture Stem for Shoulder Surgeries Receives FDA Clearance |